Recent Finacing
Recent Raise
Alector develops immuno-modulatory antibody therapeutics targeting genetically validated neuro-immune targets (e.g., TREM2, SIGLEC‑3) to treat Alzheimer’s, FTD and other neurodegenerative disorders, partnering with Adimab.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
